Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Pathology Oncology Research : POR|November 21, 2022
Thrombospondin 2 is a Functional Predictive and Prognostic Biomarker for Triple-Negative Breast Cancer Patients With Neoadjuvant ChemotherapyYuxiang Lin, E Lin, Yan Li, et al.
Biology Direct|June 3, 2024
YY1 mediated DCUN1D5 transcriptional activation promotes triple-negative breast cancer progression by targeting FN1/PI3K/AKT pathwayYuxiang Lin, Yan Li, Xiaobin Chen, et al.
Journal of Biophotonics|March 25, 2023
Combining the guidelines and multiphoton imaging methods to improve the prognostic value of tumor-infiltrating lymphocytes in breast cancerJiajia He, Deyong Kang, Meifang Xu, et al.
BMC Medicine|February 21, 2025
Multi-cancer early detection based on serum surface-enhanced Raman spectroscopy with deep learning: a large-scale case-control studyYuxiang Lin, Qiyi Zhang, Hanxi Chen, et al.
BMC Cancer|June 9, 2023
Prognostic value of tumor necrosis based on the evaluation of frequency in invasive breast cancerJianhua Chen, Zhijun Li, Zhonghua Han, et al.
Journal of the National Cancer Center|August 15, 2025
The role of infraclavicular and supraclavicular lymph nodes in breast cancer patients receiving neoadjuvant chemotherapy: implications for regional lymph node classificationYanyu Chen, Yuzhi Song, Zhonghua Han, et al.
NPJ Breast Cancer|December 14, 2025
Prognostic value of nuclear features based on tumor-associated collagen signatures in breast cancerZhijun Li, Deyong Kang, Chuan Wang, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 14, 2025
Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysisYali Wang, Jiaqi Zhan, Shunyi Liu, et al.
NPJ Breast Cancer|May 31, 2023
Impact of body mass index in therapeutic response for HER2 positive breast cancer treated with neoadjuvant targeted therapy: a multi-center study and meta-analysisLili Chen, Fan Wu, Xiaobin Chen, et al.
International Journal of Cancer|April 2, 2024
Clinical outcomes of coronavirus disease in patients with breast cancer treated with granulocyte colony-stimulating factor following chemotherapy: Triangulation of evidence using population-based cohort and Mendelian randomization analysesYali Wang, Weifeng Cai, Peng He, et al.
Pageof 9